Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro

An interactive web-based dashboard to track COVID-19 in real time

(2020) Ensheng Dong et al.   LANCET INFECTIOUS DISEASES

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

(2020) Daniel Wrapp et al.   SCIENCE

The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade

(2020) B. Coutard et al.   ANTIVIRAL RESEARCH

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues

(2020) Carly G.K. Ziegler et al.   CELL

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

(2020) Markus Hoffmann et al.   CELL

SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes

(2020) Waradon Sungnak et al.   NATURE MEDICINE

Cell entry mechanisms of SARS-CoV-2

(2020) Jian Shang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Biological properties and clinical applications of berberine

(2020) Danyang Song et al.   Frontiers of Medicine

Antiviral activity of berberine

(2020) Alicja Warowicka et al.   ARCHIVES OF VIROLOGY

The Global Phosphorylation Landscape of SARS-CoV-2 Infection

(2020) Mehdi Bouhaddou et al.   CELL

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)

(2020) W. Joost Wiersinga et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology

(2020) Natacha S. Ogando et al.   JOURNAL OF GENERAL VIROLOGY

Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2

(2020) Markus Hoffmann et al.   NATURE

Global socio-economic losses and environmental gains from the Coronavirus pandemic

(2020) Manfred Lenzen et al.   PLoS One

Potential Antiviral Options against SARS-CoV-2 Infection

(2020) Aleksandr Ianevski et al.   Viruses-Basel

Berberine Chloride is an Alphavirus Inhibitor That Targets Nucleocapsid Assembly

(2020) Judy J. Wan et al.   mBio

Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells

(2020) Na Zhu et al.   Nature Communications

Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein

(2020) Andrew D. Davidson et al.   Genome Medicine

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

(2020) Andrew Rambaut et al.   Nature Microbiology

In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2

(2020) Andrés Pizzorno et al.   ANTIVIRAL RESEARCH

SARS-CoV-2 vaccines in development

(2020) Florian Krammer   NATURE

Substantial underestimation of SARS-CoV-2 infection in the United States

(2020) Sean L. Wu et al.   Nature Communications

Regulation of Cell Signaling Pathways by Berberine in Different Cancers: Searching for Missing Pieces of an Incomplete Jig-Saw Puzzle for an Effective Cancer Therapy

(2019) Ammad Ahmad Farooqi et al.   Cancers

Novel Antiviral Activities of Obatoclax, Emetine, Niclosamide, Brequinar, and Homoharringtonine

(2019) Andersen et al.   Viruses-Basel

Berberine: Botanical Occurrence, Traditional Uses, Extraction Methods, and Relevance in Cardiovascular, Metabolic, Hepatic, and Renal Disorders

(2018) Maria A. Neag et al.   Frontiers in Pharmacology

Berberine containing quadruple therapy for initial Helicobacter pylori eradication

(2017) Di Zhang et al.   MEDICINE

Berberine inhibits enterovirus 71 replication by downregulating the MEK/ERK signaling pathway and autophagy

(2017) Huiqiang Wang et al.   Virology Journal

Obatoclax Inhibits Alphavirus Membrane Fusion by Neutralizing the Acidic Environment of Endocytic Compartments

(2016) Finny S. Varghese et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses

(2016) Finny S. Varghese et al.   ANTIVIRAL RESEARCH

The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling

(2016) Finny S. Varghese et al.   JOURNAL OF VIROLOGY

SARS and MERS: recent insights into emerging coronaviruses

(2016) Emmie de Wit et al.   NATURE REVIEWS MICROBIOLOGY

Coronaviruses and the human airway: a universal system for virus-host interaction studies

(2016) Hulda R. Jonsdottir et al.   Virology Journal

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) origin and animal reservoir

(2016) Hamzah A. Mohd et al.   Virology Journal

Role of Berberine in the Treatment of Methicillin-Resistant Staphylococcus aureus Infections

(2016) Ming Chu et al.   Scientific Reports

Current knowledge and pharmacological profile of berberine: An update

(2015) Anil Kumar et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Mumps Virus Is Released from the Apical Surface of Polarized Epithelial Cells, and the Release Is Facilitated by a Rab11-Mediated Transport System

(2015) Hiroshi Katoh et al.   JOURNAL OF VIROLOGY

Obatoclax in combination with fludarabine and rituximab is well-tolerated and shows promising clinical activity in relapsed chronic lymphocytic leukemia

(2015) Jennifer R. Brown et al.   LEUKEMIA & LYMPHOMA

Downregulation of Cellular c-Jun N-Terminal Protein Kinase and NF-κB Activation by Berberine May Result in Inhibition of Herpes Simplex Virus Replication

(2014) Siwei Song et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung cancer

(2014) Corey J. Langer et al.   LUNG CANCER

A Multicenter Phase I/II Study of Obatoclax Mesylate Administered as a 3- or 24-Hour Infusion in Older Patients with Previously Untreated Acute Myeloid Leukemia

(2014) Aaron D. Schimmer et al.   PLoS One

Coronavirus Cell Entry Occurs through the Endo-/Lysosomal Pathway in a Proteolysis-Dependent Manner

(2014) Christine Burkard et al.   PLoS Pathogens

A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer

(2012) A A Chiappori et al.   BRITISH JOURNAL OF CANCER

Interaction of Herbal Compounds with Biological Targets: A Case Study with Berberine

(2012) Xiao-Wu Chen et al.   TheScientificWorldJOURNAL

The Airway Epithelium: Soldier in the Fight against Respiratory Viruses

(2011) M. Vareille et al.   CLINICAL MICROBIOLOGY REVIEWS

Phase I Dose Finding Studies of Obatoclax (GX15-070), a Small Molecule Pan-BCL-2 Family Antagonist, in Patients with Advanced Solid Tumors or Lymphoma

(2010) J. J. Hwang et al.   CLINICAL CANCER RESEARCH

Type III IFNs: New layers of complexity in innate antiviral immunity

(2009) Nina Ank et al.   BIOFACTORS

Efficient Multiplication of Human Metapneumovirus in Vero Cells Expressing the Transmembrane Serine Protease TMPRSS2

(2008) Y. Shirogane et al.   JOURNAL OF VIROLOGY